Close Menu

No Place To Hide

When Pfizer bought Wyeth last year, the company said that it expected to cut about 15 percent of its workforce. However, on Friday, Pfizer said in a filing with the US Securities and Exchange Commission that the company will likely exceed that percentage, reports the Wall Street Journal. "At this point, it's too early to determine the extent to which we will exceed this target," says Joan Campion, a company spokesperson.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.

Researchers in France are developing a new, fast test for SARS-CoV-2 that initial testing indicates may be highly accurate, the Guardian says.

In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.